NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

Clinical trial NCT04698681 · TERMINATED

Trial details

NCT number: NCT04698681
Sponsor: Calithera Biosciences, Inc
Status: TERMINATED
Study type: OBSERVATIONAL

Non-Small Cell Lung Cancer Non-squamous Non-small-cell Lung Cancer Non-Squamous Non-Small Cell Neoplasm of Lung KEAP1 Gene Mutation NRF2 Mutation NFE2L2 Gene Mutation

Start date: 2021-01-19
Primary completion: 2021-11-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.